Europe New Car Registrations Rise 12.8% In December: ACEA

Fullei Fresh Recall Alfalfa Sprouts For E. Coli Concerns

Miami, Florida-based Fullei Fresh is recalling Alfalfa Sprouts citing the detection of Shiga toxin producing E.coli (STEC.), the U.S. Food and Drug Administration said.

The affected Fullei Fresh brand alfalfa sprout with lot number 336 comes in 8 ounce retail packs and 5 lb. bulk cardboard boxes.

They were shipped to distributors and retailers in Florida between December 9 and 23, 2022. No other lots or products are affected.

Shiga toxin producing E.coli is an organism that can cause foodborne illness, which primarily impacts elderly individuals, children, and people with weakened immune systems. Symptoms may include stomach cramps, diarrhea, and vomiting.

The agency noted that STEC is a bacterial strain that is not part of the company’s routine microbial testing conducted in compliance with the FDA’s Produce Safety Rule Subpart M on every lot being produced. It was detected upon sampling of finished product by the FDA.

However, there have been no known illnesses reported to date in connection with this product.

Consumers are urged to discard the affected product.

For More Such Health News, visit

Just Eat Posts Positive Adj. EBITDA In H2; To Maintain Focus On Profitability

Just Eat N.V. (JET.L) reported adjusted EBITDA of approximately 16 million euros for full year 2022 compared to minus 350 million euros, previous year. The Group generated adjusted EBITDA of approximately 150 million euros in second half of 2022, a material improvement from first half of 2022, driven by improved Revenue per Order, Delivery costs per Order and Overheads & Opex.

Full year 2022 Gross Transaction Value or GTV was stable compared with 28.2 billion euros in the prior year, driven by a higher Average Transaction Value and positive FX movements, which offset lower Order volumes.

Just Eat expects to deliver a positive adjusted EBITDA of approximately 225 million euros in 2023. The long-term objectives for the Group remain unchanged.

For more earnings news, earnings calendar, and earnings for stocks, visit

Currys Plc 10-weeks Like-for-like Sales Decline

Currys plc (CURY.L), a retailer of technology products and services on Wednesday said that for the 10 weeks ended 7 January 2023, like-for-like revenue for the peak period declined 6% year over year.

UK & Ireland declined 5% whereas the International business declined 7% during the period.

Alex Baldock, Group Chief Executive, commented, “Internationally, it remains tough and we continue to face into intense, but temporary, market pressures.”

The group also affirmed its medium-term guidance of at least 3.0% adjusted EBIT margin by 2024/25.

The company, however, said its UK & Ireland performance continued to strengthen and that it was confident of delivering adjusted profit before tax between 100-125 million pounds in the current year.

Shares of Currys closed Tuesday’s trading at 59.95 pence, down 5.30 pence or 8.12 percent from the previous close.

Omega Diagnostics Sees EBITDA Loss In FY; Unable To Fulfil Current Orders Before Year End

Omega Diagnostics Group PLC (ODX.L) issued a trading update which reflects lower than expected revenue, significant back-end phasing of orders, but a stronger opening order book for fiscal 2024. Full year revenues from the Health and Nutrition business are now expected to be in the range of 7.5-8.0 million pounds for the year ended 31 March 2023. This will result in an EBITDA loss from continuing operations of approximately 1.0 million pounds. Year-end cash levels are expected to remain substantial and will be approximately 5.0 million pounds.

Omega Diagnostics noted that it has faced several headwinds that have impacted the ability to fulfill orders ahead of 31 March 2023. Whilst the current order book is 2.5 million pounds and further orders are expected, a number of orders will move into fiscal 2024, the Group said.

Jag Grewal, CEO of Omega, said: “We are now bringing forward our plans to improve our manufacturing capabilities in order to meet expected demand. We remain confident in our decision to focus our growth plans on the US market, as it remains the largest market for food sensitively testing globally.”

Looking forward, the Group still fully expects fiscal 2024 to be a year of significant revenue growth and a return to positive EBITDA. The Group noted that it has identified a number of opportunities to improve operational efficiency and manufacturing capability in the near term.

For more earnings news, earnings calendar, and earnings for stocks, visit

Europe New Car Registrations Rise 12.8% In December: ACEA

European passenger car registrations climbed for the fifth month in a row in December, but at a slower pace than in November, as substantial decline was observed in the Spanish car market, monthly data from the Brussels-based European Automobile Manufacturers’ Association, or ACEA, showed on Wednesday.

New car sales in the European Union rose 12.8 percent year-on-year following a 16.3 percent growth in November, the ACEA said. The number of units sold totaled 896,967 in December versus 795,130 units in the corresponding month last year.

Among the four major markets, Germany and Italy had an extremely strong end to 2022, posting double-digit increases of 38.1 percent and 21.0 percent, respectively.

However, car markets in Spain stood on the back foot at the end of the year, with sales falling notably by 14.1 percent. In the case of France, new passenger car registrations were almost broadly unchanged, dropping marginally by 0.1 percent.

During the year 2022, the European Union passenger car market contracted by 4.6 percent, mainly due to the impact of component shortages in the first half of the year.

Despite improvement between August and December 2022, cumulative volumes stand at 9.3 million units, the region’s lowest level since 1993, the ACEA said.